腫瘤壞死因子受體超家族成員7(TNFRSF7)活性蛋白
Active Tumor Necrosis Factor Receptor Superfamily, Member 7 (TNFRSF7)
CD27; S152; T14; Tp55; CD27L receptor;
- 編號APB043Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點7.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1080 ¥ 2700 ¥ 5400 ¥ 16200 ¥ 40500
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
SDS-PAGE圖
-
Figure. Western Blot; Sample: Recombinant TNFRSF7, Human.
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
活性實驗
TNFRSF7 (Tumor necrosis factor receptor superfamily member 7), also known as CD27 antigen, is a member of the TNF-receptor superfamily. This receptor is thought to be involved in tumor necrosis factor-activated receptor activity by binding with TNFs. Thus, a binding ELISA assay was conducted to detect the association of TNFRSF7 with TNFa. Briefly, recombinant human TNFRSF7 were diluted serially in PBS with 0.01%BSA (pH 7.4). Duplicate samples of 100uL were then transferred to TNFa-coated microtiter wells and incubated for 2h at 37°C. Wells were washed with PBST and incubated for 1h with anti-TNFRSF7 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37°C. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of TNFRSF7 with TNFa was shown in Figure 1 and this effect was in a dose dependent manner.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB043Hu01 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB043Hu01 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB043Hu01 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)多克隆抗體 | WB; IHC; ICC; IP. |
| FAB043Hu01 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)多克隆抗體 | Flow cytometry. |
| LAB043Hu71 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| FAB043Hu41 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)多克隆抗體(藻紅素標(biāo)記) | Flow cytometry. |
| FAB043Hu51 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)多克隆抗體(別藻藍(lán)蛋白標(biāo)記) | Flow cytometry. |
| FAB043Hu81 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)多克隆抗體(異硫氰酸熒光素標(biāo)記) | Flow cytometry. |
| MAB043Hu22 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB043Hu21 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)單克隆抗體 | WB; IHC; ICC; IP. |
| RAB043Hu21 | 腫瘤壞死因子受體超家族成員7(TNFRSF7)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| FAB043Hu02 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)單克隆抗體 | Flow cytometry. |
| FAB043Hu42 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)單克隆抗體(藻紅素標(biāo)記) | Flow cytometry. |
| FAB043Hu52 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)單克隆抗體(別藻藍(lán)蛋白標(biāo)記) | Flow cytometry. |
| FAB043Hu82 | 抗腫瘤壞死因子受體超家族成員7(TNFRSF7)單克隆抗體(異硫氰酸熒光素標(biāo)記) | Flow cytometry. |
| SEB043Hu | 腫瘤壞死因子受體超家族成員7(TNFRSF7)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB043Hu | 腫瘤壞死因子受體超家族成員7(TNFRSF7)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
